Morning, Tuesday, 20th November 2018
Sixty One Whitehall, London SW1A 2ET
THIS EVENT IS CPD CERTIFIED
This seminar will be a timely opportunity to discuss the next steps for genomic medicine in the NHS - looking at key issues for regulation, challenges for adoption and priorities for research.
It follows the announcement by the Health and Social Care Secretary of the ambition to sequence five million genomes in the UK over the next five years.
The seminar will be an opportunity to consider the early indications from the new NHS Genomic Medicine Service as it becomes fully operational in October - as well as the next steps for NHS Genomic Medicine Centres (GMCs) as they aim to deliver the pledge of 90,000 samples of DNA from patients and family members with rare disease and cancer by September 2018.
Delegates will discuss the priorities for evaluating the evidence and sharing learning from the 100,000 Genomes Project - with the Project aiming to have completed sequencing by the end of the year - and assess the opportunities to advance other elements of personalised medicine by building upon the infrastructures established.
Planned sessions will examine the Government’s recent response to the Commons Science and Technology Committee’s report, Genomics and genome editing in the NHS, which addressed concerns around the need for investment in NHS digital infrastructure and training, along with capturing the commercial value of NHS datasets.
Attendees will assess the next steps for education and training, focusing on the progress of the Genomics Education Programme, which looks to embed genomics into relevant training courses. Delegates will also discuss priorities for patients, including key issues for patient data and ensuring public trust and support.